Shares: Buy Gsk

: The market has finally rewarded GSK's pivot into a pure-play biopharma company following its spin-off of Haleon. Pipeline Acceleration :

: Major product approvals are expected in 2026 for Bepirovirsen (Chronic Hepatitis B) and Tebipenem (UTIs). buy gsk shares

Below is an overview of the current investment case for buying GSK shares. 📈 The Bull Case: Momentum and Growth : The market has finally rewarded GSK's pivot

: While long-term momentum is high, short-term technical indicators show a recent consolidation phase , with some analysts suggesting the stock is a "hold" or "reduce" candidate at current levels after hitting recent peaks. buy gsk shares

GSK remains a staple for income-seeking investors, with management showing a commitment to increasing payouts: